Nathan Connell: Transforming Surgical Care with Tranexamic Acid
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article by Brett L. Houston et al, published in NEJM, adding:
”Sometimes the most important advances in medicine are not the newest, most expensive therapies.
A new trial published in the New England Journal of Medicine (NEJM Group) highlights the impact of tranexamic acid, or TXA, in major noncardiac surgery.
TXA is a low-cost medication that helps stabilize blood clots and reduce bleeding.
In more than 8,000 patients across 10 hospitals, a hospital-wide TXA policy reduced red blood cell transfusions from 9.8% to 7.4%, without an increased rate of venous thromboembolism at 90 days.
That matters, because it suggests that using TXA in this scenario is a practical, scalable intervention that leads to:
- Fewer transfusions
- Better stewardship of a limited blood supply
- Potential benefit in health systems with constrained resources
Blood transfusion is lifesaving, but blood is also precious. Interventions like TXA remind us that improving outcomes does not always require high-cost technology.
Sometimes it requires using simple, evidence-based tools consistently and thoughtfully.
For patients, clinicians, hospitals, and global health systems, this is exactly the kind of high-value care we should pay attention to.”
Title: Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery
Authors: Brett L. Houston, Daniel I. McIsaac, Rodney H. Breau, Salmaan Kanji, Peter Greenstreet, Meghan Andrews, Sinziana Avramescu, Hema S. Bagry, Robert Balshaw, Jayesh Daya, Kaitlin Duncan, Christopher C. Harle, Eric Jacobsohn, Tina Kerelska, Marshall Pitz, Paul Komenda, Sarah McIsaac, Tim Ramsay, Tarit Saha, Alan Tinmouth, Angela Recio, Daniel Szoke, Marshall Tenenbein, Sarah Slagerman, Dayna Solvason, Robert Talarico, Dean A. Fergusson, Ryan Zarychanski
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!